70934 149 30 Master Bottle Label Approval Rev B 02 19
Topiramate
Product Images NDC 70934-149
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70934-149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Topi (8768070b 575a 48af 8b99 76ca6dcf2087 01)
Topi (8768070b 575a 48af 8b99 76ca6dcf2087 02)
The text appears to be a graph caption indicating cumulative rates for time to an unknown event, with decreasing rates over time as seen by the descending line on the graph. The numbers on the x-axis go up from 0 to 450 in increments of 50, but the specific unit is not available due to the . The text mentions a p-value of 0.0002, indicating potential statistical significance.*
Figure 2: Reduction In 4-week Migraine Headache Frequency(studies 10 And 11 For Adults And Adolescents) (8768070b 575a 48af 8b99 76ca6dcf2087 03)
The text describes the change in the average monthly migraine period rate during the double-blind phase of a study using two doses of Topamax (100 mg/day and 200 mg/day) compared to the baseline. The change was a significant increase of 56%. The asterisks indicate the level of statistical significance.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
